Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02547779 · ClinicalTrials.gov registry record · NA
Isotonic Solutions and Major Adverse Renal Events Trial in the Non-Medical Intensive Care Unit (SMART-SURG)
A NA study of Critical Illness and Acute Kidney Injury, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 10,421
- Enrollment target
- 1
- Study location
NCT02547779 is a NA study of Critical Illness and Acute Kidney Injury that has completed, run by Vanderbilt University. The registered enrollment target is 10,421 participants, above the 3,024-participant average among 91 other Critical Illness trials with a reported enrollment target (245% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02547779, a NA study of Critical Illness and Acute Kidney Injury, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10,421 participants
- Enrollment target
- 1
- Study location
Study Summary
The administration of intravenous fluids is ubiquitous in the care of the critically ill. Commonly available isotonic crystalloid solutions contain a broad spectrum electrolyte compositions including a range chloride concentrations. Recent studies have associated solutions with supraphysiologic chloride content with hyperchloremia, metabolic acidosis and renal vasoconstriction, acute kidney injury and renal replacement therapy, and increased mortality but no large, randomized-controlled trials have been conducted. SMART-SURG will be a large, cluster-randomized, multiple-crossover trial enrolling critically ill patients from the non-medical ICUs at Vanderbilt University from October 2015 until April 2017. The primary endpoint will be the incidence of Major Adverse Kidney Events in 30 days after enrollment (MAKE30 is the composite of death, new renal replacement, or persistent renal dysfunction at discharge).
Conditions Studied
Interventions
- OTHER 0.9% Saline
- OTHER Physiologically-balanced isotonic crystalloid
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,421 participants |
| Start Date | 2015-10-01 |
| Est. Completion | 2017-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02547779
The ClinicalTrials.gov registry entry for NCT02547779 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10,421 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,024-participant average among 91 other Critical Illness trials with a reported enrollment target (245% higher). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which 0.9% Saline is the first listed.
NCT02547779 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT02547779 about?
NCT02547779 is a clinical study titled "Isotonic Solutions and Major Adverse Renal Events Trial in the Non-Medical Intensive Care Unit (SMART-SURG)". The administration of intravenous fluids is ubiquitous in the care of the critically ill. Commonly available isotonic crystalloid solutions contain a broad spectrum electrolyte compositions including a range chloride concentrations. Recent studies have associated solutions with supraphysiologic chlo...
What is the current status of trial NCT02547779?
This trial is currently completed. It is a NA study. The enrollment target is 10,421 participants. The study started on 2015-10-01. Estimated completion is 2017-06-30.
What conditions does trial NCT02547779 study?
This clinical trial studies the following conditions: Critical Illness, Acute Kidney Injury.
What interventions are being tested in trial NCT02547779?
The interventions under investigation include: 0.9% Saline (OTHER), Physiologically-balanced isotonic crystalloid (OTHER).
Who is sponsoring clinical trial NCT02547779?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02547779 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Improving Needs Among Older Adults
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
12-hour Time Limited Feeding in Critical Care
RECRUITING · NA
-
PUSH-IT Continuing Enteral Feeds for Tracheostomy
RECRUITING · NA
-
Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.